Treatment with pterostilbene simultaneously reduced the expression levels of c-MYC and hTERT in breast cancer cells, indicating that pterostilbene may downregulate hTERT expression in these cells by inhibiting c-MYC. The gene discussed is MYC; the disease is breast carcinoma.